Nasal immunization with plague F1-V recombinant protein mucosal vaccine induces systemic and mucosal immune responses in Balb/c mice

WU Xiu-fang,YU San-ke,XIE Ying-guo,WANG Dong,YUAN Yuan,XING Li,WU Su-qin,WANG Xi-liang

DOI: https://doi.org/10.3969/j.issn.1000-8861.2006.03.009

2006-01-01

Abstract:Objective To investigate the effects of plague recombinant protein F1-V mucosal vaccine on the mucosal and systemic immunity in mice.Methods Plague recombinant protein F1-V mucosal vaccine was produced by mixing plague F1-V recombinant antigen with the adjuvant rCT-B (recombinant cholera toxin unit B).Balb/c mice were nasally immunized by the vaccine(once per week) for 4 weeks and sacrificed in week 5.The specific IgG and IgA to plague in sera of the mice were detected by indirect ELISA;the specific sIgA to plague in nasal solution,lung solution,intestinal,and vaginal solution of the mice were detecting by ELISA;the cell phenotypes of inoculated or separated NALT,NP,spleens,PP nodes,and groin lymphocytes were detected by FACS.Results Intranasal immunization of mice with rCT-B combined with plague recombinant protein F1-V significantly enhanced serum IgG and mucosal IgA levels compared with immunization with the antigens alone.The 5∶1 formulation of plague mucosal vaccine was the optimal formulation for eliciting serum titers compared with other formulations.Conclusion Plague recombinant protein F1-V mucosal vaccine induce not only systemic immune response through enhancing the levels of IgG and IgA,but also mucosal immune response by increasing the level of sIgA,which suggests that rCT-B could improve the effect of protective immunity against subsequent challenge infection of plague.